Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ARRY | US
0.04
0.62%
Healthcare
Biotechnology
30/06/2024
04/10/2024
6.45
6.48
6.54
6.27
Array Technologies Inc. manufactures and sells ground-mounting tracking systems used in solar energy projects in the United States Spain Brazil Australia and internationally. The company operates in two segments Array Legacy Operations and STI Operations. Its products include DuraTrack HZ v3 a single axis tracker; Array STI H250 to deliver a lower levelized cost of energy with tracker system; Array OmniTrack; and SmarTrack a software product that uses site-specific historical weather and energy production data in combination with machine learning algorithms to identify the optimal position for a solar array in real time to enhance its energy production. The company was founded in 1989 and is headquartered in Albuquerque New Mexico.
View LessPrice Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
63.8%1 month
86.1%3 months
83.8%6 months
75.3%67.30
7.23
5.11
1.18
0.41
9.83
1.63
0.16
158.44M
979.92M
979.92M
-
14.12
-76.80
-49.60
11.81
4.78
22.30
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.91
Range1M
1.91
Range3M
6.50
Rel. volume
0.79
Price X volume
27.88M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Relay Therapeutics Inc. | RLAY | Biotechnology | 6.53 | 1.06B | 0.62% | n/a | 7.50% |
Autolus Therapeutics Plc | AUTL | Biotechnology | 3.98 | 1.06B | 0.25% | n/a | 54.69% |
AnaptysBio Inc | ANAB | Biotechnology | 33.98 | 1.03B | -2.91% | n/a | 3835.68% |
Aurinia Pharmaceuticals Inc | AUPH | Biotechnology | 7.12 | 1.02B | 0.00% | n/a | 23.58% |
Pharvaris B.V | PHVS | Biotechnology | 18.2 | 982.94M | -0.66% | n/a | 0.04% |
Sana Biotechnology Inc. Common Stock | SANA | Biotechnology | 4.23 | 941.03M | -2.98% | n/a | 29.02% |
Silence Therapeutics plc | SLN | Biotechnology | 18.64 | 933.49M | 1.30% | n/a | 0.16% |
Prothena Corporation plc | PRTA | Biotechnology | 16.86 | 906.74M | 1.08% | n/a | 2.08% |
Zymeworks Inc | ZYME | Biotechnology | 12.57 | 893.07M | 1.45% | n/a | 4.94% |
Applied Therapeutics Inc | APLT | Biotechnology | 7.7 | 884.31M | -8.22% | n/a | 0.30% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 9.83 | 0.76 | Expensive |
Ent. to Revenue | 1.63 | 3,674.48 | Cheaper |
PE Ratio | 67.30 | 38.01 | Expensive |
Price to Book | 5.11 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 83.83 | 74.67 | Par |
Debt to Equity | 1.18 | -1.82 | Expensive |
Debt to Assets | 0.41 | 0.26 | Expensive |
Market Cap | 979.92M | 3.73B | Emerging |